Manufacturers must navigate complex regulatory landscapes, understand diverse cultural nuances, and prioritize patient access in each region.
Thomas Ruggia
Advertisement
President and CEO, Samsara Vision
Articles by Thomas Ruggia
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
The Importance of Suppressor Cells in Tumor Progression
2
Johnson and Johnson Acquiring Halda Therapeutics in $3 Billion Definitive Agreement
3
Agentic AI Will Transform the Business of Life Sciences
4
Pharmaceutical Executive Daily: Novo Nordisk's Leadership Restructure
5
